We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An organization of radiologists is pointing to a new report that shows an overwhelming percentage of radiology procedures would be reimbursed at below the cost to provide them if related provisions in deficit-reduction legislation go through.
The FDA said Sept. 18 that it is making the first simple and portable lead test system accessible to more certified healthcare outlets, including healthcare clinics, mobile health units and schools.
A new study appears to support the device industry's contention that advanced technology is worth its high cost, and that reimbursement policies should reflect that value.
Invibio this week launched Endolign composite, a new biocompatible carbon fibre-reinforced thermoplastic material for use in implantable load bearing medical device applications requiring blood, bone or tissue contact of more than 30 days.
Sinusitis affects 37 million Americans, leading to a wide range of symptoms, which include nasal discharge, headaches or facial pain, and chronic obstruction.
What if a doctor could keep tabs on a patient's heart failure symptoms on a daily basis, detecting subtle increases in weight and blood pressure, the tell-tale signs of worsening heart failure, and summoning the patient to the hospital before they themselves were aware that anything was wrong?
Quidel Corporation, a leading provider of rapid point-of-care (POC) diagnostic tests, today launched their QuickVue RSV test upon receiving clearance from the FDA.
On August 21, 2006, BD received a subpoena issued by the Attorney General of the State of Illinois which seeks documents and information relating to BD's participation as a member of Healthcare Research & Development Institute, LLC.
Boston Scientific Corp. settled a product liability lawsuit over one of its recalled Guidant heart defibrillator models for an undisclosed amount, a plaintiff's lawyer said.
Researchers at Johns Hopkins University have come up with new procedures that allow clinicians to safely conduct magnetic resonance imaging (MRI) scans of patients implanted with any of 24 types of heart devices manufactured by St. Jude Medical, Guidant and Medtronic, a new study says.